|
Government
Jun 15
|
Coakley urging funding for fishery researchBOSTON – Calling scientific research “critical” to the future of the state’s fishing industry, Attorney General Martha Coakley is urging the legislature to keep funding for fisheries research within the proposed fiscal 2014 budget. |
|
Main Street
Jun 15
By Rhonda Miller |
This energy drink swings for fencesA growing Rhode Island energy beverage company started with one of those offhand, but perceptive, comments that rang true enough to launch a company. |
|
Biotechnology
Jun 12
By Meg Tirrell |
Amgen says ovarian cancer drug meets goal of late-stage studyAmgen Inc., the world’s largest biotechnology company by sales, said its experimental drug for recurrent ovarian cancer met a late-stage study goal, helping patients live 1.8 months longer without the disease progressing. |
|
Health Care
Jun 1
|
R.I. Hospital dedicates renovated family roomRhode Island Hospital recently celebrated the dedication of a completely renovated family room in its Comprehensive Cancer Center. The renovations were made possibly through a gift from the Michael H. Flanagan Foundation, a nonprofit that serves Bone Marrow Transplant and Leukemia induction patients and their families. |
|
Business Women
Jun 1
By Robin Respaut Contributing Writer |
A career that has grown its way to a full circleWhen Nancy Ryan Gray was a doctoral student at the Pennsylvania State University in 1983, she attended a research conference in New Hampshire with a crowd of scientists whose writings she had been studying avidly. The moment changed her life. |
|
Manufacturing
May 29
By PBN Staff
|
Cadence breaks ground on Cranston expansionMedical device manufacturer Cadence Inc. broke ground Wednesday on a 34,000-square-foot expansion of its Cranston facility. |
|
Biotechnology
May 29
By Alex Wayne, Kanoko Matsuyama and Shannon Pettypiece |
Amgen, Astellas to develop cancer, bone treatments in JapanAmgen Inc., one of the world’s largest biotechnology companies by sales, announced a partnership with Japanese drugmaker Astellas Pharma Inc. to bring five of its experimental therapies to market in that country. |